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OBJECTIVES: To develop and externally validate a prognostic model for poor recovery after 33 
ankle sprain. SETTING AND PARTICIPANTS: Model development used secondary data analysis 34 
from 584 participants in a UK multicentre randomised clinical trial. External validation used 35 
data from 682 participants recruited in 10 emergency departments across the UK for a 36 
prospective observational cohort. OUTCOME AND ANALYSIS: Poor recovery was defined as 37 
presence of pain, functional difficulty or lack of confidence in the ankle at 9-months after 38 
injury. Twenty-three baseline candidate predictors were included together in a multivariable 39 
logistic regression model to identify the best predictors of poor recovery. Relationships 40 
between continuous variables and the outcome were modelled using fractional polynomials. 41 
Regression parameters were combined over 50 imputed datasets using Rubin’s rule. To 42 
minimise over-fitting, regression coefficients were multiplied by a heuristic shrinkage factor 43 
and the intercept re-estimated. Incremental value of candidate predictors assessed at 4-44 
weeks after injury was explored using decision curve analysis and the baseline model 45 
updated. The final models included predictors selected based on the Akaike Information 46 
Criterion (p<0.157). Model performance was assessed by calibration and discrimination. 47 
RESULTS: Outcome rate was lower in the development (6.7%) than in the external validation 48 
dataset (19.9%). Mean age (29.9 and 33.6 years), BMI (26.3 and 27.1 kg/m2), pain when 49 
resting (37.8 and 38.5 points) or bearing weight on the ankle (75.4 and 71.3 points) were 50 
similar in both datasets. Age, BMI, pain when resting, pain bearing weight, ability to bear 51 
weight, days until assessment, and injury recurrence were the selected predictors. The 52 
baseline model had fair discriminatory ability (c-statistic 0.72; 95%CI: 0.66-0.79) but poor 53 
calibration. The updated model presented better discrimination (c-statistic 0.78; 95%CI: 0.72-54 
0.84), but equivalent calibration. CONCLUSIONS: The models include predictors easy to assess 55 
clinically and show benefit when compared to not using any model. Registry number: 56 
ISRCTN12726986. 57 
Keywords: prognosis, clinical prediction rule, logistic model, ankle injuries, sprains and strains   58 
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STRENGTHS AND LIMITATIONS OF THIS STUDY 59 
 This is the first study to develop and externally validate a tool to predict poor recovery after 60 
ankle sprain, including a wide range of clinically relevant candidate predictors. 61 
 Despite containing information on the outcomes of interest and numerous prognostic 62 
variables, the development dataset was not originally acquired to build a prognostic model. 63 
 The number of events in the development dataset was relatively small compared to the 64 
number of candidate predictors examined. 65 
 Yet, the prognostic models were developed using robust statistical methods, adjusted for 66 
overfitting and reported according to the most recent relevant guidelines available. 67 
 Generalisability of findings is enhanced by the multi-centre characteristic of the datasets used 68 




Ankle sprains are one of the most common musculoskeletal injuries, representing up to 5% 71 
of all emergency department (ED) attendances in the UK.[1] Despite heterogeneity in 72 
sampling frame (e.g. restricted to elite athletes or excluding older people), inception, and 73 
follow-up time points, studies have indicated that approximately 30% of people have 74 
persistent problems one year after ankle sprain.[2, 3] In a large multi-centre randomised 75 
clinical trial conducted in the UK, a similar proportion (30%) of participants had poor outcome 76 
at 9 months.[4] Other studies indicate a recovery plateau at around 9 months, and residual 77 
disability after this point to be persistent.[5] 78 
In the acute phase after a sprain, physical examination of the ankle is often difficult due to 79 
swelling and pain. Predicting prognosis at this stage is uncertain and based on clinical 80 
judgement. When concerned about the injury severity, clinicians operate a system of review 81 
within one week in a trauma clinic (or equivalent service), which allows some resolution of 82 
swelling and reassurance about the presence of other significant mechanical derangement.[6] 83 
The Ottawa ankle rule is also an alternative to reduce the requirement for imaging without 84 
missing important fractures.[7] 85 
In 2008, Van Rijn et al conducted a systematic review on the clinical pathway and prognostic 86 
factors of ankle sprain recovery and found a single eligible study concluding that high levels 87 
of sports activity have prognostic value for residual symptoms.[2] In a more recent systematic 88 
review, we have identified nine studies reporting results for baseline prognostic factors of 89 
recovery after an acute ankle sprain.[8] Age, gender, swelling, range of motion, weight 90 
bearing ability, pain, injury severity, palpation/stress score, injury mechanism, self-reported 91 
recovery, re-sprain, MRI determined number of sprained ligaments and bone bruise were 92 
reported as independent predictors of poor recovery. However, almost all studies performed 93 
poorly on the risk of bias assessment, mainly due to incomplete or inadequate reporting 94 
standards for study participants, attrition, methods of assessment for predictors, confounding 95 
and statistical methods used, so results should be interpreted with caution. 96 
To the best of our knowledge, there are no externally validated prognostic models for 97 
recovery after acute ankle sprain. Polzer et al. developed an algorithm to help clinicians with 98 
the diagnosis and treatment of acute ankle injuries, but this is considerably based on expert 99 
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judgements and do not use currently recommended methods for the development of 100 
prognostic models.[9] A robustly developed and validated prognostic model could help to 101 
target treatment better and improve outcomes for people who have an ankle sprain.[10]  102 
Therefore, the development of a new prognostic model, considering a range of plausible 103 
candidate predictors, and ideally with the evaluation of its performance on an external 104 
dataset (external validation), is indicated. 105 
The aim of our study was to develop and externally validate the SPRAINED (Synthesising a 106 
clinical Prognostic Rule for Ankle Injuries in the Emergency Department) prognostic model, to 107 
identify people at risk of poor recovery at nine months after acute ankle sprain. 108 
METHODS 109 
Study populations and data collection 110 
Data from the Collaborative Ankle Support Trial (CAST), were used to develop the prognostic 111 
model.[11] CAST was a pragmatic multicentre randomised controlled trial on the 112 
effectiveness of different mechanical ankle supports compared with a double-layer tubular 113 
compression bandage for managing severe ankle sprains. The trial sample comprised 584 114 
participants aged 16 years or older, with an ankle sprain of grade 2 or 3, attending eight EDs 115 
in the UK between April 2003 and July 2005, within 7 days after their injury, and were not 116 
able to fully bear weight on the injured ankle at baseline. Further data was collected at 4 and 117 
12 weeks, and 9 months after randomisation. The CAST methods and a CONSORT flow 118 
diagram are available elsewhere.[11] 119 
To assess the model’s performance in an external population, the SPRAINED prospective 120 
observational cohort was recruited. Participants were aged 16 years or above, with acute 121 
ankle sprains of any grade, attending 10 NHS EDs across England, within 7 days after their 122 
injury. Patients were excluded if they presented with an ankle fracture (except flake fractures 123 
< 2mm) or any other recent (< 3 months) lower limb fracture. Participants were not 124 
randomised, nor did they receive any interventions other than usual care at each site. The 125 
study recruited 682 participants between July 2015 and March 2016. Data collection covered 126 
clinical and socio-demographic information collected at ED presentation (baseline), with 127 
follow-up assessments at 4 weeks, 4 and 9 months after the initial injury, either by self-128 
reported paper-based forms sent back to the study office by postal mail, electronic 129 
questionnaires, or telephone interviews. The SPRAINED questionnaires included all variables 130 
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selected as predictors in the model and the components of the outcome of interest. All 131 
participants of both studies have provided written informed consent before any data 132 
collection took place. Ethics approval was from the National Research Ethics Committee (REC) 133 
(London - Chelsea), REC number 15/LO/0538, on 10th April 2015. The study protocol was 134 
registered on 30th April 2015; registry number ISRCTN12726986. 135 
Definition of outcome 136 
A prognostic model was developed to predict ‘poor recovery’ at 9 months after an acute ankle 137 
sprain. Poor recovery was defined as the presence of pain, lack of confidence in the ankle 138 
(persistent feeling of giving way) or functional difficulty.[12, 13] The presence of these 139 
symptoms was assessed by patient-reported responses given to specific items (P1, Q3 and 140 
Q4) of the Foot and Ankle Outcome Score (FAOS).[14] Participants who answered one or more 141 
of these questions with any of the two most extreme response options (“daily” or “always” 142 
P1; “severely” or “extremely” for Q3 or Q4) were considered to have poor outcome. 143 
Baseline candidate predictors 144 
Thirty-two baseline candidate predictors were considered plausible predictors of poor 145 
outcome and pre-selected from a pool of 170 variables available in the CAST dataset 146 
(Supplemental Tables 1 and 2). This initial selection was made internally by the research 147 
team, taking into account the results from our systematic literature review [8] and the 148 
conclusions from a consensus group meeting convened for the SPRAINED study, which 149 
included clinicians, medical researchers, statisticians and PPI representatives. The 32 150 
candidate predictors included socio-demographic information (e.g. age, sex, body mass index 151 
(BMI), education, employment status); pre-injury quality of life, mobility and lifestyle 152 
indicators (e.g. engagement in sports activities); clinical data on injury presentation; baseline 153 
(post-injury) mobility levels, pain and weight-bearing status (Supplemental Table 3). 154 
At this stage, variables were excluded or combined before statistical modelling if they had 155 
60% or more of missing information; displayed high collinearity (r ≥ 0.8) with another 156 
candidate predictor; presented empty or low cell counts (n < 5) when tabulated against the 157 
outcome; were the offending variable causing perfect prediction during the multiple 158 
imputation process (Supplemental Table 4; Supplemental Figure 1). 159 
Sample size considerations 160 
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It is widely recommended that the dataset used to develop a prognostic tool should contain 161 
a minimum of 5-10 outcome events per variable (EPV) included as a predictor in the 162 
model.[15-20] After the exclusion of nine baseline candidate predictors for the reasons 163 
described above, 23 variables from baseline remained as candidate predictors. However, 164 
some of these predictors were categorical variables with more than two levels, so we ended 165 
with 35 candidate parameters, meaning the EPV ratio was approximately three. 166 
As to the best of our knowledge this was the first study aiming to develop prediction models 167 
to assess the risk of poor recovery after an acute ankle sprain, we opted for relaxing the EPV 168 
rule in favour of including more potentially important predictors. Nevertheless, we adopted 169 
several strategies to minimise bias and overfitting, as described below. 170 
Descriptive analysis 171 
Baseline and 4-week follow-up characteristics of the CAST and SPRAINED participants were 172 
summarised using means, standard deviations (SDs) and ranges for continuous variables, or 173 
counts and percentages for categorical variables. Inspection of extreme values (outliers) took 174 
place to confirm whether they were clinically plausible and visual assessment of data 175 
distribution for continuous predictors in both datasets was conducted. No formal statistical 176 
tests were performed to compare the values between the studies. 177 
Prognostic model development 178 
Using logistic regression, we developed the prognostic model to predict the probability of 179 
poor recovery. We performed multiple imputation using chained equations (MICE) [21] to 180 
handle missing data, with 50 imputed datasets created. Continuous variables were kept as 181 
continuous to avoid loss of prognostic information,[22] and the shape of their relationship 182 
with the outcome studied and modelled with nonlinear functions such as fractional 183 
polynomials (FPs) where appropriate.[23] As several continuous variables were included in 184 
the models, we used the multivariable fractional polynomial (MFP) algorithm.[24, 25] 185 
Multiple imputation and fractional polynomials were combined using the mfpmi function in 186 
Stata.[26] The estimated regression parameters (coefficients and variances) were combined 187 
over the 50 imputed datasets using Rubin’s rule.[27, 28] After identifying the best 188 
transformation terms for continuous variables, the final model included predictors (and 189 
respective transformations, where applicable) selected from the full multivariable model with 190 
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all candidate predictors based on the Akaike Information Criterion (equivalent to a p-value < 191 
0.157).[29] To adjust for over-fitting, due to small EPV, we multiplied all regression 192 
coefficients by the heuristic shrinkage factor,[30] then re-estimated the intercept. All model 193 
assumptions were checked and differences between incomplete and imputed datasets 194 
inspected. Imputed data from all 584 participants were included in all analyses. 195 
Incremental value analysis and model update 196 
In addition to the baseline predictors, 14 additional variables from the CAST 4-weeks follow-197 
up questionnaire were also selected as potential predictors that could increase the model’s 198 
prognostic ability (Supplemental Table 3). First, all additional 4-weeks candidate predictors 199 
were included together in the final baseline model and only those achieving a p-value < 0.157 200 
were considered for inclusion in the updated model (i.e. a model including baseline and 4-201 
weeks predictors). Finally, the updated model was compared with the original baseline model 202 
using decision curve analysis (DCA) plots to determine whether the inclusion of additional 203 
predictors reflected in increased net benefit.[31, 32] 204 
External validation: Model performance 205 
We assessed the model performance in the prospectively collected SPRAINED cohort. Missing 206 
data in the SPRAINED cohort was handled using MICE, creating 50 imputed datasets. 207 
Performance was evaluated by assessing calibration and discrimination. Calibration is the 208 
agreement between observed and predicted probabilities of poor outcome. Calibration was 209 
assessed graphically using calibration plots, with observed risks plotted on the y-axis against 210 
predicted risks on the x-axis.[33, 34] The calibration plot was created by regressing the 211 
outcome on the predicted probability using a locally weighted scatter plot smoother (lowess). 212 
The calibration plot was also supplemented with estimates of the calibration slope and 213 
intercept. Models with perfect calibration will have a calibration slope of 1 and intercept 0 214 
(i.e., prediction lying on the 45 line). Calibration plots followed recommendations of 215 
overlaying calibration curves from each imputed data set.[35] Discrimination reflects the 216 
ability of the model to distinguish between participants who did and did not experience an 217 
event during the study period. Discrimination was assessed using the c-statistic, where a value 218 
of 0.5 represents chance and 1 represents perfect discrimination.[36] Finally, to estimate the 219 
benefit of using the developed models, patients were ranked according to their estimated 220 
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risks. These were used to calculate the number of people per 1000 identified as being at high 221 
risk according to selected thresholds and how many of these went on to present the outcomes 222 
compared with not using the model. Individual probabilities of developing the outcomes were 223 
estimated by applying the developed prognostic models to each participant in the SPRAINED 224 
imputed datasets. We assessed the performance of both the baseline and updated models 225 
using imputed data from all 682 participants. 226 
Patient involvement 227 
A PPI representative was involved in the study from the beginning, providing advice on key 228 
aspects of the study design, including the definition of the research question, choice of the 229 
outcome and selection of relevant candidate predictors during the consensus group meeting. 230 
They will be consulted for the public dissemination of any product arriving from this research. 231 
Reporting 232 
We followed the TRIPOD Statement for the reporting of our study.[37] 233 
RESULTS 234 
Baseline characteristics for the CAST (development) and SPRAINED (validation) cohorts are 235 
summarised in Table 1. On average, participants were slightly older in SPRAINED than in CAST. 236 
Participants in SPRAINED had an average BMI within the overweight category, likewise those 237 
in CAST. The mean pain scores when resting or bearing weight on the ankle of SPRAINED 238 
participants were also similar to those observed for CAST participants. Differently from CAST, 239 
in SPRAINED about half of participants were female, the majority presented to an ED within 240 
2 days from injury for assessment and were able to bear some weight on their injured ankles 241 
(Table 1).  242 
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Table 1. Baseline characteristics of the participants in the CAST trial and SPRAINED prospective observational 
cohort. 
Variable 
CAST Trial  SPRAINED Cohort 
Mean (SD) Min - Max  Mean (SD) Min - Max 
Age (years) 29.88 (10.77) 16 – 72  33.62 (13.38) 16 – 89 
Height (m) 1.73 (0.98) 1.47 – 2.01  1.72 (1.02) 1.50 – 2.01 
Weight (kg) 78.56 (15.44) 39.92 – 133.36  80.44 (18.13) 44.50 – 180 
Body mass index (kg/m2) 26.34 (5.19) 16.07 – 53.77  27.08 (5.70) 17.31 – 64.30 
Pain when resting (score) 37.75 (23.49) 0 – 100  38.50 (22.50) 0 – 100 
Pain when bearing weight (score) 75.42 (19.61) 0 – 100  71.30 (21.00) 0 – 100 
 Frequency %  Frequency % 
Sex      
Male 337 57.71  327 47.95 
Female 247 42.29  355 52.05 
Days from injury to assessment      
0-2 118 44.87  614 90.03 
3 or more 145 55.13  68 9.97 
Able to bear weight at Baseline 
assessment   
   
No 446 77.03  179 26.44 
Yes 133 22.97  498 73.56 
Recurrent sprain      
No 517 90.38  583 91.38 
Yes 55 9.62  55 8.62 
Current employment      
None 132 22.60  161 23.68 
Part time 92 15.75  92 13.53 
Full time 360 61.64  427 62.79 
Injury mechanism      
At home 99 18.00  144 21.56 
Practicing sports 203 36.91  230 34.43 
At work 79 14.36  91 13.62 
Outside, in public 169 30.73  203 30.39 
Table 2 shows the rates of poor recovery in the CAST trial and SPRAINED cohort datasets, as 243 
well as the number of its component symptoms, at 9 months after injury. There was a lower 244 
rate of poor recovery in the SPRAINED cohort than observed in the CAST trial, but the 245 
percentage of missing data for the outcome was similar in both studies.  246 
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Table 2. Outcome and respective symptoms components rates and proportion of missing data in the CAST 
trial and SPRAINED prospective observational cohort. 
 Pain Lack of confidence Instability Poor recovery Missing data TOTAL1 
CAST 84 (14.4%) 42  (7.2%) 67 (11.5%) 116 (19.9%) 144 (24.7%) 584 
SPRAINED 3 (0.4%) 23 (3.4%) 37 (5.4%) 46 (6.7%) 155 (22.7%) 682 
Note: Poor recovery defined as the presence of one or more of the following symptoms: pain, lack of 
confidence or instability/difficulty with the ankle. 
Table 3 displays the summary of the final multivariable models (predictor’s coefficients, 247 
respective 95% confidence intervals and p-values). Seven of the 23 baseline candidate 248 
predictors were selected for inclusion in the baseline model: age, BMI, pain when resting, 249 
pain when bearing weight, days from injury to assessment, ability to bear weight and whether 250 
or not the injury was a recurrent sprain. The best fit for all continuous predictors were linear 251 
transformations (mean subtractions) and were later incorporated into the model by updating 252 
the intercept accordingly (Supplemental Table 5).  253 
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(baseline plus 4-weeks predictors) 
Coefficient 95% CI p 
Shrunk 
coefficient 
 Coefficient 95% CI P 
Shrunk 
coefficient 
Age 0.027 0.006 0.048 0.014 0.019  0.018 -0.005 0.040 0.127 0.015 
BMI 0.031 -0.014 0.076 0.178 0.022  0.025 -0.022 0.072 0.292 0.021 
Pain when resting 0.016 0.005 0.027 0.005 0.011  0.010 -0.002 0.022 0.107 0.008 
Pain when bearing weight 0.019 0.004 0.035 0.016 0.014  0.014 -0.002 0.030 0.092 0.012 
Pain when bearing weight 4 wks. after injury - - - - -  0.022 0.012 0.032 < 0.001 0.018 
Days from injury to assessment (reference 0-2)            
3 or more 0.854 0.068 1.640 0.034 0.605  0.702 -0.117 1.520 0.092 0.591 
Able to bear weight at Baseline (reference No)            
Yes -0.792 -1.376 -0.207 0.008 -0.561  -0.802 -1.412 -0.192 0.010 -0.676 
Recurrent sprain (reference No)            
Yes 1.180 0.417 1.944 0.003 0.836  1.170 0.386 1.953 0.004 0.985 
Intercept -1.580 -2.152 -1.008 < 0.001 -1.363  -1.543 -2.128 -0.958 < 0.001 -1. 420 
95% CI: 95% confidence interval 
Linear terms selected by the MFP for continuous predictors: Age – 29.88; BMI – 26.32; Pain when resting – 37.75; Pain when bearing weight – 75.40; Pain when bearing weight 




Only pain when bearing weight on the sprained ankle at 4 weeks after injury was included in 255 
the updated model (baseline plus 4-week predictors) (Table 3). By inspecting the DCA plots 256 
shown in Figure 1 it is possible to see a clear net benefit gain over the entire range of 257 
thresholds when using the updated prognostic model in comparison to the baseline model or 258 
considering all patients (or no patient) at risk of having poor recovery after an acute ankle 259 
sprain. 260 
Shrinkage suggested both prognostic models (baseline and updated) had predictor-outcome 261 
associations that were too large. The heuristic shrinkage factor for the coefficients of the 262 
predictors in the baseline prognostic model was 0.71. For the updated version (baseline plus 263 
4-weeks predictors), the estimated heuristic shrinkage factor was 0.84. The shrunk 264 
coefficients and intercepts for the final models are presented in Table 3. 265 
Overall, discrimination of the baseline model was fair, with a c-statistic of 0.72 (95%CI: 0.66 266 
to 0.79). Calibration of the baseline prognostic model in the external validation dataset was 267 
poor though, as can be evidenced by inspecting the calibration plot with overlaid calibration 268 
lines from the 50 imputed datasets (Figure 2). The calibration slope was 1.13 (95%CI: 0.76 to 269 
1.5) and the calibration intercept was -0.71 (95%CI: -0.98 to -0.44). The updated model 270 
(baseline plus 4-weeks predictors) presented better discriminatory ability in the SPRAINED 271 
dataset than the baseline model (c-statistic = 0.78; 95%CI: 0.72 to 0.84), but equivalent 272 
calibration, with an intercept closer to zero (-0.51; 95%CI: -0.78 to -0.24) and slope slightly 273 
further from one (1.17; 95%CI: 0.86 to 1.48). 274 
Table 4 shows how many of 1000 people would be identified as being at high risk (based on 275 
thresholds of 5, 10, 15, and 20%) using the developed prognostic models, and how many of 276 
these would actually present poor recovery 9 months after an acute ankle sprain. There seems 277 
to be little difference between the baseline and updated models, with both identifying similar 278 
numbers of patients who would experience a poor outcome after an acute ankle sprain. 279 
However, less patients are deemed at high risk by using the updated model for (less false 280 
positives) across all thresholds of predicted probability suggesting that reassessing the 281 
patients at 4 weeks after the injury might be beneficial to a more accurate prediction of their 282 
probability of poor outcome. Using any of the models is clearly beneficial, when compared to 283 
not using any model (i.e. considering all patients – or no patients – as high risk of developing 284 
poor outcome). 285 
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Table 4. Models performance (numbers at risk and outcomes identified) at varying risk thresholds for 1000 
patients. 
Selected thresholds 
Number of patients at risk  Number of events 
High risk Low risk  Identified Not identified 
Consider all high risk 1000 0  85 0 
Predicted probability as per baseline 
model   
 
  
≥5% 971 39  85 0 
≥10% 797 203  74 11 
≥15% 543 457  63 22 
≥20% 351 649  52 33 
Predicted probability as per updated 
model (baseline plus 4-weeks predictors)   
 
  
≥5% 882 118  85 0 
≥10% 517 483  71 14 
≥15% 358 642  56 29 
≥20% 259 741  41 44 
DISCUSSION 286 
We developed a prognostic model to predict a composite outcome representing the presence 287 
of at least one of the following symptoms at 9 months after an acute ankle sprain: pain, 288 
functional difficulty or lack of confidence in the ankle. The model presented fair 289 
discriminatory ability in a prospectively collected external validation cohort, but poor 290 
calibration. Including an additional variable collected at 4 weeks after the injury (pain when 291 
bearing weight on the injured ankle) improved the discriminatory ability and calibration of 292 
the model. The models included predictors that are easily collected and provided reasonable 293 
predictions of poor recovery for patients with acute ankle sprain. 294 
In a recent systematic review, we have reported that some of the variables selected for 295 
inclusion in our prognostic model, have been previously identified as important predictors of 296 
short, medium or long term recovery after ankle sprain.[8] According to O’Connor et al. age 297 
and weight bearing ability are predictors of ankle function, as measured by the Karlsson 298 
function score, both at 4 weeks and 4 months after injury.[38] Akacha et al. also 299 
demonstrated that age was an important predictor of slower and incomplete recovery after 300 
ankle sprain, as measure by the Foot and Ankle Outcome Score.[39] The magnitude of pain at 301 
rest at 3 months has also been shown to have prognostic value for poorer self-reported 302 
recovery at 12 months after ankle sprain by Van Middelkoop et al.[40] On the other hand, 303 
Findings regarding recurrence of ankle sprain are conflicting. McKeon et al., reported that 304 
recurrent ankle sprain was not a significant predictor of time to return-to-play after an ankle 305 
injury.[41] This is contrary to reports of an association between recurrent sprains and chronic 306 
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ankle instability reported in a systematic review conducted by Pourkazemi et al. [42] One 307 
possible explanation for these contradictory results may be the nature of the outcomes 308 
investigated in each study. When more subjective aspects of recovery (such as ankle function 309 
or instability) are considered in the definition of the endpoint, like in the present study, re-310 
spraining the ankle seems to be an important predictor of recovery. 311 
The inclusion of BMI in the prognostic model is another issue that deserves consideration. 312 
Although not statistically significant in the final multivariable logistic regression analysis, 313 
according to AIC (p<0.157), we have decided to keep BMI in the model for several reasons. 314 
First, this decision prevented  another round of predictor selection, which could increase 315 
over-fitting. The model building process was not solely based on statistical rationale, and BMI 316 
was considered to be an important predictor by clinicians during our consensus group 317 
meeting. BMI is an easy to assess surrogate measure of body weight that is frequently 318 
collected at clinical routine and one that most patients know how to calculate themselves. 319 
Finally, its inclusion does not add much complexity to the models. 320 
To the best of our knowledge, this is the first study to develop and externally validate a 321 
prognostic model to predict a clinically relevant outcome in people with acute ankle sprains 322 
exploring a wide range of clinically plausible candidate predictors. We used robust statistical 323 
methods to select the predictors and assess the model´s performance in a large external 324 
prospective cohort. Generalisability of the findings are enhanced by the multi-centre data 325 
from the CAST and SPRAINED cohorts that represented a range of district general and major 326 
trauma centres. The observational cohort we prospectively recruited for SPRAINED is 327 
representative of patients presenting to EDs in the UK. We followed the most recent and 328 
complete guidelines available on the reporting of prognostic model development,[37] and 329 
applied recommended methods to minimise overfitting. For example, continuous variables, 330 
whenever possible, were kept as continuous to avoid loss of information. Nonlinear 331 
relationships were investigated using the best variables transformations found by 332 
multivariable fractional polynomials. The study included an internal correction for model 333 
optimism (shrinkage of regression coefficients and re-estimation of intercepts) as well as a 334 
prospective external validation phase. The amount of missing data in the external validation 335 
dataset, which is commonplace in studies of this nature, was considerably smaller than that 336 
16 
 
observed in the development dataset. Finally, we performed missing data imputation to 337 
produce a set of 50 complete datasets and enable robust analyses. 338 
Limitations of the SPRAINED study are acknowledged. Firstly, data used to develop the 339 
prognostic models were from a prior randomised controlled trial (CAST), so were not 340 
originally intended to fulfil this aim. However, the CAST cohort did represent the best dataset 341 
available, with information on the symptoms and clinical events of interest, and a wide range 342 
of the candidate prognostic variables considered to have predictive ability. Secondly, the CAST 343 
dataset used to develop the prognostic model was relatively small compared to the number 344 
of candidate predictors.[15-20] As previously highlighted, the low EPV observed for the two 345 
developed models might have contributed to the optimism found for both and, therefore, to 346 
the poor calibration on the external validation dataset. Thirdly, the amount of missing data 347 
observed in the development dataset. Because of that, a number of candidate predictors 348 
were omitted before the process of data imputation, to avoid instability of the imputation 349 
models. Therefore, some important predictors could have conceivably been missed in the 350 
development phase of the SPRAINED study. Finally, the rates of poor outcome in the 351 
SPRAINED cohort were lower than in the CAST trial and those reported in previous systematic 352 
reviews.[2, 3] These variations in poor outcome rates and clinically important differences in 353 
baseline characteristics included in the prognostic model (such as days from injury to clinical 354 
assessment and ability to bear weight on the injured ankle) highlight the issue of different 355 
sampling frames. 356 
Clinical examination of acute ankle sprain is challenging as tolerance of physical examination 357 
tests is often poor due to pain and swelling. Imaging is often not routinely available. A 358 
prognostic tool could enable better targeting of treatments such as immobilisation casts, 359 
which although effective can be inconvenient to patients, to those deemed at low risk of poor 360 
outcome. On the other hand, it has the potential to help clinicians targeting treatments such 361 
as surgery and physiotherapy to patients who are at highest risk of poor outcome. 362 
The SPRAINED prognostic model benefits from including predictors that are easy to measure, 363 
and usually assessed in clinical routine. Given the herby discussed limitations in its predictive 364 
performance, we suggest that its value would be in assisting the clinician to estimate the 365 
probability of a poor outcome, instead of being used as a decision making tool in isolation. 366 
Improved predictive performance of the models with the addition of information on pain 367 
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when bearing weight at 4 weeks indicates that re-assessment of prognosis after the acute 368 
phase is worth consideration for patients initially deemed to have elevated probability of 369 
delayed recovery. Besides, as it is an easy-to-use instrument, patients themselves can 370 
estimate their probability of poor outcome and gain some reassurance in their decisions to 371 
seek for further medical assistance or not. 372 
If implemented in clinical practice, clinicians should be aware that there is a degree of 373 
uncertainty associated to the calculated risk of poor outcome when using the SPRAINED 374 
prognostic model. This uncertainty can lead to over or under referral of patients to review 375 
clinics or referral treatment such as physiotherapy. Future work could examine how well the 376 
model performs in comparison (or addition) to the clinician impression. Moreover, we 377 
recommend further research to evaluate the impact of using the SPRAINED prognostic model 378 
in clinical practice to predict patient outcomes and to assess the acceptability and uptake of 379 
the tool by clinicians in the EDs. 380 
In conclusion, the SPRAINED prognostic models performed reasonably and despite some 381 
miscalibration show benefit in identifying patients at high risk of poor outcome after an acute 382 
ankle sprain. The models may assist clinical-decision making when assessing and advising 383 
people with ankle sprains in the ED setting and when deciding on on-going management. The 384 
models benefit from using predictors that are simple to obtain during routine clinical 385 
assessment. 386 
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FIGURE LEGENDS 538 
Figure 1. Decision curve analysis for the baseline and updated (baseline plus 4-weeks 539 
predictors) prognostic models. 540 
Figure 2. Calibration plots for the baseline (left) and updated (right) SPRAINED prognostic 541 
models, overlaying calibration lines derived from the analyses of 50 imputed datasets. 542 
